Patients' Perspectives on Antidepressant Discontinuation and the Pharmacists' Role
Basic & Clinical Pharmacology & Toxicology · 2026-04 · 138 (4)
DOI: 10.1111/bcpt.70207 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2026-03-01. Written by Samah Bouarfa and 6 co-authors. Institution: Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centre, Amsterdam, the Netherlands. Major MEDLINE topics: Pharmacists, Antidepressive Agents, Professional Role, Health Knowledge, Attitudes, Practice. Cited 1 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Stichting MAG, ZonMw.
Abstract (original language)
Antidepressant (AD) discontinuation care asks for tailored support and alignment with patients' expectations, needs and wishes. However, studies on patients' experiences and perspectives regarding the contribution of the pharmacist to AD discontinuation care are limited. The aim was to gain a deeper understanding of patients' perspectives regarding guidance during AD discontinuation and patients' views on the contribution of the pharmacist. A qualitative, explorative study was conducted with 15 semistructured face‐to‐face and video call interviews. Inclusion criteria were age ≥ 18 years and current or past use of ADs. The audiotapes were transcribed verbatim, coded and analysed by two researchers. The following four themes were identified: (1) experiences with ad use and discontinuation, (2) attitudes and behaviour towards AD discontinuation, (3) expectations and perceptions towards AD discontinuation and (4) needs regarding AD discontinuation. False beliefs about ADs and past negative experiences with AD discontinuation shape beliefs of patients that amount to a reluctance to discontinue ADs. The most urgent needs of patients were timely receiving guidance, including clear and relevant information from accessible, knowledgeable and trustable healthcare providers (HCPs). Pharmacists' easy accessibility, pharmacotherapeutic knowledge, expertise and capabilities should be put to use, as they may help meeting patients' needs on AD discontinuation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
- Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
- Department of Primary and Community Care, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of General Practice, Amsterdam UMC, Amsterdam, the Netherlands.
- Service Pharmacy Koning, Amsterdam, the Netherlands.
- Foundation Saphia, Amsterdam, the Netherlands.
ORCID profiles: Samah Bouarfa, Jacqueline G Hugtenburg
Funding
- Stichting MAG
- ZonMw
Cite
APA
Bouarfa, S., Göttgens, W., Ligthart, S. A., Maarsingh, O. R., Kooij, M. J., Bet, P. M., & Hugtenburg, J. G. (2026). Patients' Perspectives on Antidepressant Discontinuation and the Pharmacists' Role. Basic & Clinical Pharmacology & Toxicology, 138(4). https://doi.org/10.1111/bcpt.70207
Vancouver
Bouarfa S, Göttgens W, Ligthart SA, Maarsingh OR, Kooij MJ, Bet PM, et al. Patients' Perspectives on Antidepressant Discontinuation and the Pharmacists' Role. Basic & Clinical Pharmacology & Toxicology. 2026;138(4). doi:10.1111/bcpt.70207
BibTeX
@article{Bouarfa2026,
author = {Bouarfa, Samah and Göttgens, Wilma and Ligthart, Suzanne A and Maarsingh, Otto R and Kooij, Marcel J and Bet, Pierre M and Hugtenburg, Jacqueline G},
title = {Patients' Perspectives on Antidepressant Discontinuation and the Pharmacists' Role},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {138},
number = {4},
doi = {10.1111/bcpt.70207}
}
EUVIMED